The female genital organ consists of the vagina, uterus, tubes and ovaries. If there is a disruption in any of these regions, the chance of pregnancy is also eliminated. When the mother and father candidates are considered as a whole, if there is a disruption in any of them, it becomes difficult to conceive naturally and in this case, the most frequently applied method is in vitro fertilization treatment.

Who is IVF treatment recommended for?

In vitro fertilization can be applied if both tubes of the expectant mother are blocked. Because this situation prevents the sperm and egg from meeting in the tube and the sperm from fertilizing the egg.

If there is a decrease in the egg reserve of the expectant mother, then in vitro fertilization treatment should be applied without losing time, because the egg reserve will continue to decrease in the future. In addition, if the expectant mother’s age is 40 and over, the success rates of other methods other than in vitro fertilization are very low.

In vitro fertilization can also give successful results in cases where sperm or eggs are frozen due to cancer treatment. If there are structural or numerical problems in the chromosomes of men or women, the possibility of live birth can be increased by choosing embryos without chromosome problems among the embryos developed by in vitro fertilization method.

In men, if the sperm count is 5 million or less in 1 milliliter, IVF treatment will be the right option. In addition, if the sperm forward motility is 10% or less than the sperm percentage, if the sperm morphology is insufficient and if there is azoospermia, which is the absence of sperm cells in the semen, the chance of pregnancy can be increased with in vitro fertilization.

In addition to these groups and situations, in-vitro fertilization treatment can give successful results in cases where pregnancy is not achieved despite two or three vaccinations, in cases where the couple’s desire for children is longer than 5-6 years, and in cases where the mother and father are carriers in terms of single gene diseases.